DB18686ExperimentalProtein Based Therapies
MBP134 is a pan-ebolavirus cocktail comprising two broadly neutralizing human antibodies. It is under investigation for the treatment of Sudan ebolavirus (SUDV).
- Code names
- MBP-134
Which companies are running trials of MBP134, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account